Specific code 2015 ICD-9-CM Diagnosis Code 209.30
Malignant poorly differentiated neuroendocrine carcinoma, any site
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM 209.30 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 209.30 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: 209.30 converts approximately to:
  • 2015/16 ICD-10-CM C7A.1 Malignant poorly differentiated neuroendocrine tumors
Approximate Synonyms
  • Malignant carcinoid tumor, poorly differentiated
  • Malignant neuroendocrine carcinoma, poorly differentiated
  • Malignant neuroendocrine tumor, poorly differentiated
  • Malignant poorly different neuroendocrine cancer
  • Malignant poorly differentiated carcinoid tumor
  • Malignant poorly differentiated neuroendocrine tumor
  • Primary malignant neuroendocrine tumor, poorly differentiated
209.30 Excludes
Applies To
  • High grade neuroendocrine carcinoma, any site
  • Malignant poorly differentiated neuroendocrine tumor NOS
ICD-9-CM Volume 2 Index entries containing back-references to 209.30:
  • Carcinoma (M8010/3) - see also Neoplasm, by site, malignant
    • neuroendocrine
      • high grade (M8240/3) 209.30
      • malignant poorly differentiated (M8240/3) 209.30
  • Tumor (M8000/1) - see also Neoplasm, by site, unspecified nature
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 209.30 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.